ANOCA/INOCA Recognition — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Microvascular angina or vasospastic angina should be reassessed with specific testing (CFR measurement, acetylcholine provocation); ANOCA/INOCA affects up to 50% of patients with stable chest pain and non-obstructive arteries
The 2024 ESC CCS Guidelines highlight that ANOCA/INOCA (angina/ischaemia with non-obstructive coronary arteries) is underdiagnosed and undertreated. Up to 50% of patients undergoing angiography for stable chest pain have non-obstructive coronary arteries, and many of these have demonstrable microvascular dysfunction or vasospasm on specific testing. Dismissing these patients as 'non-cardiac' leads to persistent symptoms, reduced quality of life, impaired work capacity, and increased healthcare utilisation. The recommended workup includes: coronary flow reserve (CFR) measurement, index of microvascular resistance (IMR), and acetylcholine provocation testing during invasive angiography. Effective treatments exist for both endotypes (microvascular angina and vasospastic angina).
Reference: ESC (2024): Guidelines for the Management of Chronic Coronary Syndromes